Add Yahoo as a preferred source to see more of our stories on Google. Close-Up Of Donated Blood In Bag Your blood type affects everything, from a predisposition to certain diseases to your heart ...

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...

USA: Oral semaglutide may lower the risk of heart failure-related events in people with type 2 diabetes who already have heart failure, without increasing serious adverse events, a secondary analysis ...

An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had ...

Do you remember your blood type? Many Americans don't have this important medical information. Along with being necessary info in a crisis, your blood type is also linked to certain medical conditions ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

Data are lacking about the relationship between type 2 diabetes and the risks of heart failure (HF) among people with elevated cardiac biomarkers. This information is particularly scant among Black ...

The American Heart Association is warning that heart disease and stroke are on the rise for women and young girls, as new ...

Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...

Obesity, diabetes and high blood pressure are fueling increases in cardiovascular disease, even among much younger women, the ...

Oral semaglutide reduced the number of significant heart failure-related events in people with type 2 diabetes (T2D), a new study has found. The largest benefit was observed in a particularly ...